Head & Neck Network

Head & Neck Network Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Head & Neck Network, Medical and health, Indio, CA.

Head & Neck Network is an online and open access platform dedicated to raising awareness and providing reliable, verified information about head and neck cancers.

IOWA CANCER REPORT FINDS FARMERS HAD FEWER CARCERS COMPARED WITH THE GENERAL POPULATIONThe study found that overall, far...
06/22/2026

IOWA CANCER REPORT FINDS FARMERS HAD FEWER CARCERS COMPARED WITH THE GENERAL POPULATION

The study found that overall, farmers were less likely to be diagnosed with most cancers. However, farmers had higher-than-expected rates of prostate and lip cancer.

The study suggests that high exposure to some insecticides may increase the risk of aggressive prostate cancer. The higher risk of lip cancer was believed to be mainly due to excess sun exposure and higher rates of chewing to***co use.

Full article: https://www.kcrg.com/2026/03/13/iowa-cancer-report-finds-farmers-had-fewer-cancers-compared-with-general-population/

06/19/2026

MACROPHAGE VS CANCER CELL

Source: Macrophage vs Cancer cell
- “Chris Ferriola “ Official
Youtube Channel for this video and world_of_biology_wob2

Link to watch original Video on Youtube channel
https://youtu.be/3sODeSWeltY?
si=CmYs8S1g7-NdST7n

06/17/2026

WARNING 5 SIGNS OF ESOPHAGEAL CANCER
Esophageal cancer may not cause symptoms early on. Symptoms of esophageal cancer usually happen when the disease is advanced.
Don’t Ignore the Signals!
Signs and symptoms of esophageal cancer include:
* Difficulty swallowing.
* Chest pain, pressure or burning.
* Coughing or hoarseness.
* Weight loss without trying.
* Worsening indigestion or heartburn.
Early detection saves lives!


CANCER IS AN ANCIENT FOECancer is an ancient foe, not the modern malady it’s often portrayed as. In 2016, a 1.7 million ...
06/15/2026

CANCER IS AN ANCIENT FOE

Cancer is an ancient foe, not the modern malady it’s often portrayed as.

In 2016, a 1.7 million year old osteosarcoma was reported by Dr Edward John Odes (a doctoral student in Anatomical Sciences from the University of the Witwatersrand Medical School, South Africa) and colleagues, representing the oldest documented malignant hominin cancer.

The earliest known descriptions of cancer appear in several papyri from ancient Egypt. The Edwin Smith Papyrus was written around 1600 BC, and contains a description of cancer, as well as a procedure to remove breast tumours by cauterization, stating that the disease has no treatment. However, incidents of cancer were rare, because age is the highest risk factor and life expectancy was not more than 40 years. In a study by the University of Manchester, only one case was found “in the investigation of hundreds of Egyptian mummies, with few references to cancer in literary evidence.”

Lesions in Skull E270, in the Duckworth Laboratory collection at the University of Cambridge, have long been heralded as some of the earliest evidence for cancer in humans. Scientists believe the bony indentations in the 4000-year-old-skull from ancient Egypt were made by malignant tumors. A study released in Frontiers in Medicine suggests someone tried to cut it out. Looking at the skull under a microscope, and assisted by micro-CT scans, scientists say they have found cut marks around the lesions indicative of surgical tumor removal. It’s impossible to determine whether the cuts were made before or after the 30- to 35-year-old man’s death, the authors note. But either way, they indicate either the surgical study or treatment of cancer.

Source: Wikipedia and New York Times

06/12/2026

P53 IN DNA DAMAGE

p53 is a sentinel protein recruited rapidly in response to DNA damage. p53 slides along the DNA until it finds a critical site, to which it binds. p53 then sends the message, to halt cell division until DNA is repaired, or If damage is too severe, the cell is destroyed. p53 is therefore known as the ‘guardian of the genome! A tiny change in p53 results in a structure that is unable to securely bind to the critical site. This means no decisions can be made about whether to repair DNA or destroy the cell. Without functional p53, cells can accumulate more and more DNA damage, possibly leading to cancer.

06/10/2026

HOW COMMON ARE HEAD AND NECK CANCERS?

Head and neck cancers account for nearly 4% of all cancers in the United States.

Researchers estimated that more than 68,000 men and women in the United States would be diagnosed with head and neck cancers in 2021.

Listen and share ⬇️

BIOMARKER TEST MAY IMPROVE RISK ASSESSMENT FOR HPV-RELATED THROAT CANCERResearchers at the Ohio State University Compreh...
06/08/2026

BIOMARKER TEST MAY IMPROVE RISK ASSESSMENT FOR HPV-RELATED THROAT CANCER

Researchers at the Ohio State University Comprehensive Cancer Center are advancing the understanding of a promising blood test that could personalize treatment and surveillance for patients with human papillomavirus (HPV)-associated throat cancer. The research, published in JAMA Otolaryngology—Head and Neck Surgery, explores how a blood-based test, circulating tumor HPV DNA (ctDNA), changes before and after surgery. The study explores how tumor biology and patient factors influence ctDNA levels. The findings provide important new insight into how this ctDNA test can be used along with pathology reports to improve risk assessment and personalize treatment plans.
“We know that more than 90% of throat cancer cases are caused by HPV,” said Catherine Haring, MD, an otolaryngologist specializing in head and neck cancers and an assistant professor in the Department of Otolaryngology—Head and Neck Surgery at The Ohio State University College of Medicine. “While this type of cancer responds well to treatment, patient quality of life is impacted by radiation and chemotherapy. Improved biomarkers could help us better tailor treatment to reduce unnecessary side effects while ensuring patients receive the therapy they need.”

Full article: https://medicalxpress.com/news/2026-04-biomarker-hpv-throat-cancer.html

06/05/2026

Chewing Gum Reduces HPV and Oral Cancer–Associated Bacteria in Head and Neck Squamous Cell Carcinoma

Emerging data published in Scientific Reports, demonstrates extracts from a bioengineered chewing gum to significantly reduce the levels of 3 microbes associated with head and neck squamous cell carcinoma (HNSCC).

The medicated chewing gum displayed substantial reductions in oral human papillomavirus (HPV), Porphyromonas gingivalis (P gingivalis), and Fusobacterium nucleatum (Fnucleatum).

The research evaluated a lablab bean–derived chewing gum containing the antiviral lectin (FRIL), for microbial loads in oral samples from patients with HNSCC. The goal was to asses HPV, Porphyromonas gingivalis and Fusobacterium nucleatum, which have been implicated in tumor progression.

The data analyzed saliva and oral rinse samples from patients with HNSCC and compared microbial levels following exposure to the investigational chewing gum extract.

Following treatment with the bean-derived lectin formulation, HPV levels were reduced by approximately 93% and 80% in saliva and oral rinse samples, respectively. The effect is attributed to FRIL-mediated binding of viral glycoproteins, which promotes aggregation and reduces viral availability for host cell entry.

Full article: https://www.pharmacytimes.com/view/emerging-data-shows-chewing-gum-reduces-hpv-and-oral-cancer-associated-bacteria-in-hnscc

06/03/2026

AIR POLLUTION IN HEAD AND NECK CANCER

Listen and share ⬇️

Global study links alcohol to rising cases of lip and oral cavity cancerHeavy alcohol consumption has sharply increased ...
06/01/2026

Global study links alcohol to rising cases of lip and oral cavity cancer

Heavy alcohol consumption has sharply increased the global burden of lip and oral cavity cancers over the past three decades, with the steepest rise seen in Southeast Asia and in lower-middle SDI regions (the SDI reflects the average education level of a country’s population) according to a new analysis based on Global Burden of Disease 2021 data provisionally accepted for publication in Frontierson Sept. 15.

The authors report that disability-adjusted life years (DALYs) attributable to alcohol-related lip and oral cavity cancers reached 1,191,084 in 2021, up from 628,484 in 1990 — an increase of about 90 per cent over the period.

Southeast Asia recorded the sharpest increases, with DALYs up 326% and deaths up 357% since 1990.

The authors project that from 2022 to 2045 the burden will continue to climb, especially among men.  
The study team, led by Suzhou Stomatological Hospital in China, urges targeted action in low- and middle-income countries: lifestyle interventions, earlier screening and optimized resource allocation to curb future burden.

Meanwhile, the World Health Organization classifies alcohol as an established carcinogen and estimates that in 2019 alcohol caused 2.6 million deaths worldwide. In the same year, 4.4% of cancers diagnosed globally and 401,000 cancer deaths were attributable to alcohol consumption.

Address

Indio, CA
92201

Alerts

Be the first to know and let us send you an email when Head & Neck Network posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share